Corelight Secures Series D Funding and Receives $75M Series D Seed Round
Corelight Security has announced the release of the CoreLight Defender Series D. The company states that this is a first look at the new product line for the global markets and that it will be available in the second quarter of next year. The company further states that the product will be based on the patented technology of Zeek Systems, which it acquired in August 2021 for an undisclosed amount. The CoreLight system will utilize the Zeek Chipset, which includes several different components. Each component of the chipset will perform a different function to enhance the security of the network and help reduce costs.
The company further claims that the components of the CoreLight stack will include: The Zeek Enterprise Gateway, which it states is a highly efficient switching and routing device that offer guaranteed secure connectivity with zero-traffic losses along with a low-latency, high-speed interface. The Zeek Enterprise Gateway can be operated with ease and offers two unique IP-based authentication options: A private secure tunnel for enterprise intranet traffic and a public, secure network for the web. The Zeek Intranet Gateway is compliant with the Windows Server 2021 platform and supports multiple SIDs with one SSID. The company further claims that the private secure tunnel has a 100% success rate with no-ping time and is managed from a user interface located on the firewall of the company’s infrastructure. The company’s website states that users can establish secure VPN connections between PCs and servers and that this capability is useful for applications such as email, Webmail, and VOIP communication.
The company also claims to have added the capability of automatically monitoring and managing the flow of traffic across the network, which it calls Stream Analytics. This enables the network managers to analyze the traffic that is passing through the enterprise firewall in real-time and makes intelligent decisions based on real-time visibility. This technology will allow network managers to take actions to block or reduce the amount of bandwidth that is being consumed by malicious applications, which the company claims will prevent the hackers from “modding” the systems. In a separate blog post on the company’s website, Qi Lu, chief technology officer of CoreLight, stated that these new technologies will enable companies to defend their intellectual property from foreign attacks, enhance productivity, and reduce costs.
Company’s next step:
In another article on CNET’s Science Daily blog, Qi Lu stated that the company’s next step would be to expand its research into the area of artificial intelligence. This is an increasingly important area with technology advancements demonstrating that artificial intelligence will enable computing devices to think, reason, and remember. Furthermore, he said that the company is currently working on a number of research projects using artificial intelligence. These could raise the value of the company and its products in the market.
In a June 21st article on CNET’s Science Daily blog, Qi Lu stated that the company is investing more in the field of precision medicine and nanotechnology. Precision medicine refers to medical devices that are engineered to perform at optimal levels and deliver the correct drug or nutritional supplement at the right time. Nanotechnology has the ability to create exact materials and devices that are made up of atoms of different sizes. This enables engineers to create materials and devices that are capable of doing more than one task. The increase in nanotechnology could raise the value of the company in the global market and increase its market share in the global markets.
Molecular Imaging Technology Developer:
In a June 14th article on the New York Times website, molecular imaging technology developer Feng Lin revealed that he had received a six-figure research grant from the National Institutes of Health to develop next-generation image software. The software will enable engineers to simultaneously analyze tens of thousands of data samples, which will allow scientists to better understand how biological systems function. The software will also enable researchers to scale models of cells, tissues, and other biological structures and build molecular simulations that will help them understand how these systems interact. The new software will greatly improve the network’s ability to track and analyze data at higher speeds. The future of medical testing and research looks bright with the acquisition of Corelight Secured Series D Network Security and Databricks raised by the Corelight acquisition.